CDR-Life is a biopharmaceutical company that redefines antibody therapies. It develops novel therapeutics, aiming to transform the lives of people with sight- and life-threatening diseases, based on a technology for composing modular antibodies with ideal pharmacological and drug-like properties.
Products, services, technology
CDR-Life’s lead programs include novel immunotherapies that target intracellular cancer-related proteins for superior tumor-selectivity and more durable efficacy. The company’s portfolio contains several first-in-class immunotherapies against solid and liquid tumors.
CDR-Life has a strategic partnership with a global pharmaceutical company and continues to partner with leading companies that share our vision of bringing its highly innovative antibody therapies to patients.